摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N,N'-terephthalylidenebisaniline | 14326-69-3

中文名称
——
中文别名
——
英文名称
N,N'-terephthalylidenebisaniline
英文别名
p-Xylylidendianil;N-(4-((Phenylimino)methyl)benzylidene)aniline;N-phenyl-1-[4-(phenyliminomethyl)phenyl]methanimine
N,N'-terephthalylidenebisaniline化学式
CAS
14326-69-3
化学式
C20H16N2
mdl
——
分子量
284.36
InChiKey
XYMUFEVKENAHFB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    162-163 °C
  • 沸点:
    446.3±28.0 °C(Predicted)
  • 密度:
    1.02±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    4.1
  • 重原子数:
    22
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    24.7
  • 氢给体数:
    0
  • 氢受体数:
    2

SDS

SDS:495863dd4df3b0b2c43adf422b4d67e7
查看

SECTION 1: Identification of the substance/mixture and of the company/undertaking
Product identifiers
Product name : N,N'-TEREPHTHALYLIDENEDIANILINE
REACH No. : A registration number is not available for this substance as the substance
or its uses are exempted from registration, the annual tonnage does not
require a registration or the registration is envisaged for a later
registration deadline.
CAS-No. : 14326-69-3


SECTION 2: Hazards identification
Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008
Acute toxicity, Oral (Category 4), H302
Chronic aquatic toxicity (Category 4), H413
For the full text of the H-Statements mentioned in this Section, see Section 16.
Classification according to EU Directives 67/548/EEC or 1999/45/EC
Xn Harmful R22
For the full text of the R-phrases mentioned in this Section, see Section 16.
Label elements
Labelling according Regulation (EC) No 1272/2008
Pictogram
Signal word Warning
Hazard statement(s)
Harmful if swallowed.
May cause long lasting harmful effects to aquatic life.
Precautionary statement(s) none
Supplemental Hazard none
Statements
Other hazards - none

SECTION 3: Composition/information on ingredients
Substances
Formula : C20H16N2
Molecular Weight : 284,36 g/mol
CAS-No. : 14326-69-3
Hazardous ingredients according to Regulation (EC) No 1272/2008
Component Classification Concentration
N,N'-TEREPHTHALYLIDENEDIANILINE
Acute Tox. 4; Aquatic Chronic -
4; H302, H413
For the full text of the H-Statements and R-Phrases mentioned in this Section, see Section 16

SECTION 4: First aid measures
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Flush eyes with water as a precaution.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
Most important symptoms and effects, both acute and delayed
The most important known symptoms and effects are described in the labelling (see section 2.2) and/or in
section 11
Indication of any immediate medical attention and special treatment needed
no data available

SECTION 5: Firefighting measures
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides, nitrogen oxides (NOx)
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

SECTION 6: Accidental release measures
Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid dust formation. Avoid breathing vapours, mist or gas. Ensure
adequate ventilation. Avoid breathing dust.
For personal protection see section 8.
Environmental precautions
Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into the
environment must be avoided.
Methods and materials for containment and cleaning up
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed
containers for disposal.
Reference to other sections
For disposal see section 13.

SECTION 7: Handling and storage
Precautions for safe handling
Avoid contact with skin and eyes. Avoid formation of dust and aerosols.
Provide appropriate exhaust ventilation at places where dust is formed.Normal measures for preventive fire
protection.
For precautions see section 2.2.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Specific end use(s)
A part from the uses mentioned in section 1.2 no other specific uses are stipulated

SECTION 8: Exposure controls/personal protection
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and
at the end of workday.
Personal protective equipment
Eye/face protection
Safety glasses with side-shields conforming to EN166 Use equipment for eye protection tested
and approved under appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
Complete suit protecting against chemicals, The type of protective equipment must be selected
according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
For nuisance exposures use type P95 (US) or type P1 (EU EN 143) particle respirator.For higher
level protection use type OV/AG/P99 (US) or type ABEK-P2 (EU EN 143) respirator cartridges.
Use respirators and components tested and approved under appropriate government standards
such as NIOSH (US) or CEN (EU).
Control of environmental exposure
Prevent further leakage or spillage if safe to do so. Do not let product enter drains. Discharge into
the environment must be avoided.

SECTION 9: Physical and chemical properties
Information on basic physical and chemical properties
a) Appearance Form: solid
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting point/freezing no data available
point
f) Initial boiling point and no data available
boiling range
g) Flash point no data available
h) Evapouration rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower no data available
flammability or
explosive limits
k) Vapour pressure no data available
l) Vapour density no data available
m) Relative density no data available
n) Water solubility no data available
o) Partition coefficient: n- log Pow: 4,778
octanol/water
p) Auto-ignition no data available
temperature
q) Decomposition no data available
temperature
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
Other safety information
no data available

SECTION 10: Stability and reactivity
Reactivity
no data available
Chemical stability
Stable under recommended storage conditions.
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products
Other decomposition products - no data available
In the event of fire: see section 5

SECTION 11: Toxicological information
Information on toxicological effects
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitisation
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
no data available
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Additional Information
RTECS: Not available
To the best of our knowledge, the chemical, physical, and toxicological properties have not been
thoroughly investigated.

SECTION 12: Ecological information
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
PBT/vPvB assessment not available as chemical safety assessment not required/not conducted
Other adverse effects
no data available

SECTION 13: Disposal considerations
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Contact a licensed
professional waste disposal service to dispose of this material. Dissolve or mix the material with a
combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber.
Contaminated packaging
Dispose of as unused product.

SECTION 14: Transport information
UN number
ADR/RID: - IMDG: - IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA: Not dangerous goods
Transport hazard class(es)
ADR/RID: - IMDG: - IATA: -
Packaging group
ADR/RID: - IMDG: - IATA: -
Environmental hazards
ADR/RID: no IMDG Marine pollutant: no IATA: no
Special precautions for user
no data available

SECTION 15: Regulatory information
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.
Safety, health and environmental regulations/legislation specific for the substance or mixture
no data available
Chemical Safety Assessment


SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

  • 作为反应物:
    描述:
    N,N'-terephthalylidenebisaniline频那醇硼烷 作用下, 以 neat (no solvent) 为溶剂, 反应 12.0h, 以137 mg的产率得到α,α'-二苯胺基对二甲苯
    参考文献:
    名称:
    通过使用HBpin的还原胺化反应,无需催化剂和溶剂即可有效地获得N-烷基胺。
    摘要:
    已经发现了一种在无催化剂和无溶剂条件下合成结构多样的仲胺的可持续方法。这种一锅法协议可在室温下有效地工作,并且与各种空间和电子上不同的醛和伯胺兼容。值得注意的是,这种简单的方法具有可扩展性,出色的官能团耐受性,化学选择性,并且在生物相关分子的合成中也很有效。
    DOI:
    10.1039/d0ob00740d
  • 作为产物:
    描述:
    对苯二甲醛苯胺甲醇 为溶剂, 反应 1.5h, 生成 N,N'-terephthalylidenebisaniline
    参考文献:
    名称:
    二乙基硅烷作为金纳米颗粒催化还原反应中的有力试剂
    摘要:
    相对于典型的氢硅烷,二乙基硅烷在由Au纳米颗粒催化的羰基化合物,亚胺和酰胺的还原中表现出显着的反应性。
    DOI:
    10.1002/ejoc.202000483
点击查看最新优质反应信息

文献信息

  • Sulfonic acid supported on hydroxyapatite-encapsulated-γ-Fe2O3 nanocrystallites as a magnetically separable catalyst for one-pot reductive amination of carbonyl compounds
    作者:Jia Deng、Li-Ping Mo、Fei-Yang Zhao、Lan-Lan Hou、Li Yang、Zhan-Hui Zhang
    DOI:10.1039/c1gc15470b
    日期:——
    A novel, environmentally friendly procedure has been developed for the preparation of secondary or tertiary amines by one-pot reductive amination of carbonyl compounds using sodium borohydride in the presence of a magnetically recoverable sulfonic acid supported on hydroxyapatite-encapsulated-γ-Fe2O3 [γ-Fe2O3@HAP-SO3H] at room temperature. The catalyst was easily separated from the reaction mixture by applying an external magnet and reused for six cycles without significant loss of catalytic activity.
    开发了一种新的环境友好型方法,通过室温下在一锅法反应中使用硼氢化钠还原胺化羰基化合物,结合磁性可回收的磺酸基团负载于羟基磷灰石包覆的γ-Fe2O3(γ-Fe2O3@HAP-SO3H)来制备二级或三级胺。催化剂可通过外加磁场轻松从反应混合物中分离,并可重复使用六次而不会显著降低催化活性。
  • The Stereochemical Behavior of Terephthalic Schiff Bases in Addition of Dialkyl or Diaryl Phosphites
    作者:Jarosław Lewkowski
    DOI:10.1080/104265090508172
    日期:2005.1.1
    Abstract Addition of dialkyl (or diaryl) phosphites to N-alkyl terephthalic Schiff bases led exclusively to a meso-form but addition to N-aryl terephthalic Schiff bases depended on the substituent of the aryl group. Semi-empirical calculations were involved to find the reason of this phenomenon.
    摘要 亚磷酸二烷基酯(或二芳基)与 N-烷基对苯二甲酸席夫碱的加成仅产生内消旋形式,但对 N-芳基对苯二甲酸席夫碱的加成取决于芳基的取代基。为了找出这种现象的原因,需要进行半经验计算。
  • Exploration of imidazole and imidazopyridine dimers as anticancer agents: Design, synthesis, and structure–activity relationship study
    作者:Sangeetha Meenakshisundaram、Manoj Manickam、Thanigaimalai Pillaiyar
    DOI:10.1002/ardp.201900011
    日期:2019.12
    Dimerization of proteins/receptors plays a critical role in various cellular processes, including cell proliferation and differentiation. Therefore, targeting such dimeric proteins/receptors by dimeric small molecules could be a potential therapeutic approach to treating various diseases, including inflammation‐associated diseases like cancer. A novel series of bisimidazoles (13–18) and bis‐imidazo[1,2‐a]pyridines
    蛋白质/受体的二聚化在各种细胞过程中起着关键作用,包括细胞增殖和分化。因此,通过二聚体小分子靶向此类二聚体蛋白/受体可能是治疗各种疾病(包括癌症等炎症相关疾病)的潜在治疗方法。一系列新型双咪唑 (13-18) 和双咪唑并 [1,2-a] 吡啶 (19-28) 因具有抗癌活性而由席夫碱二聚体 (1-12) 设计和合成。筛选了所有合成的化合物对三种癌细胞系的抗癌活性,包括宫颈癌 (HeLa)、乳腺癌 (MDA-MB-231) 和肾癌 (ACHN)。从构效关系研究中,咪唑并[1,2-a]吡啶(19-28)显示出显着的细胞毒活性,化合物 19 和 24 显示出对所有三种细胞系的最佳抑制活性。特别是,19 和 24 对乳腺癌细胞系都非常有效(19,GI50 = 0.43 µM;24,GI50 = 0.3 µM),超过了对照阿霉素的活性(GI50 = 0.51 µM)。化合物 19 和 24 的体内抗
  • DBDA as a Novel Matrix for the Analyses of Small Molecules and Quantification of Fatty Acids by Negative Ion MALDI-TOF MS
    作者:Ling Ling、Ying Li、Sheng Wang、Liming Guo、Chunsheng Xiao、Xuesi Chen、Xinhua Guo
    DOI:10.1007/s13361-017-1881-y
    日期:2018.4.1
    Matrix interference ions in low mass range has always been a concern when using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) to analyze small molecules (<500 Da). In this work, a novel matrix, N1,N4-dibenzylidenebenzene-1,4-diamine (DBDA) was synthesized for the analyses of small molecules by negative ion MALDI-TOF MS. Notably, only neat ions ([M–H]-) of fatty
    当使用基质辅助激光解吸/电离飞行时间质谱(MALDI-TOF MS)分析小分子(<500 Da)时,低质量范围的基质干扰离子一直是一个令人关注的问题。在这项工作中,合成了一种新的基质N 1,N 4-二亚苄基苯-1,4-二胺(DBDA),用于通过负离子MALDI-TOF MS分析小分子。值得注意的是,只有纯离子([M–H] -质谱中出现无基质干扰的脂肪酸,检测限(LOD)达到0.3 fmol。DBDA对氨基酸,肽和核苷酸等其他小分子也有出色的表现。此外,使用该新型基质,根据相关系数为0.99的相关曲线对血清中的游离脂肪酸进行了定量分析。此外,还进行了UV-Vis实验和分子轨道计算,以探讨DBDA在负离子模式下作为基质的机理。目前的工作表明,DBDA基质是一种高度敏感的基质,几乎没有干扰离子可用于分析小分子。同时,DBDA能够精确定量真实生物样品中的脂肪酸。 在新窗口中打开图像 图形概要 ᅟ
  • Reductive <i>tert</i>-Butylation of Anils by <i>tert</i>-Butylmercury Halides<sup>1</sup>
    作者:Glen A. Russell、Lijuan Wang、Ragine Rajaratnam
    DOI:10.1021/jo961544f
    日期:1996.1.1
    promote a free radical chain process involving electron transfer by substrate activation and/or by increasing the electron affinity of the intermediate radicals. Since the adduct radicals formed from benzylideneanilines are more easily protonated than the parent Schiff bases, PTSA but not NH(4)(+) demonstrates substrate activation, although both proton donors promote the free radical reaction.
    叔丁基自由基加到亚苄基苯胺的碳原子上形成苯胺基自由基,在PTSA或NH(4)(+)在Me(2)SO中存在时将其质子化。ate络合物t-BuHgI(2)(-)易于还原生成的苯胺自由基阳离子。在没有质子供体的情况下,t-BuHgI还将氢原子转移到苯胺基上,得到还原性烷基化产物。质子化可促进自由基链过程,该过程涉及通过底物活化和/或通过增加中间自由基的电子亲和力进行电子转移。由于由苄叉基苯胺形成的加合物自由基比母体Schiff碱更容易被质子化,因此PTSA而不是NH(4)(+)表现出底物活化作用,尽管两个质子供体都促进自由基反应。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐